Pig liver trial offers hope for liver failure patients
NCT ID NCT07429838
First seen Feb 27, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This early-stage study tests a genetically-modified pig liver (EGEN-5784) used outside the body with a special device to temporarily support liver function in 20 adults with acute-on-chronic liver failure. Participants are not eligible for a transplant. The goal is to check safety and see if the pig liver can help reduce toxins and improve liver function during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
Contact
-
Washington University
St Louis, Missouri, 63130, United States
Contact
Conditions
Explore the condition pages connected to this study.